Literature DB >> 19877777

Endovascular obliteration of an intracranial pseudoaneurysm: the utility of Onyx.

Ricky Medel1, R Webster Crowley, D Kojo Hamilton, Aaron S Dumont.   

Abstract

Pseudoaneurysms are rare lesions with a multitude of causes, including infectious, traumatic, and iatrogenic origins. In addition, there are a number of potential treatment options, all of which require consideration to determine the most appropriate management. Historically, surgical intervention has been the method of choice, but because the histopathological features of these lesions make them largely unsuitable for clipping, trapping or excision is often required. More recently endovascular methods have been used, including coil embolization, stent reconstruction, or parent artery occlusion. Although these methods are often successful, situations arise in which they are not technically feasible. The authors describe such a case in a pediatric patient with an iatrogenic pseudoaneurysm. Onyx was used to embolize the lesion and the results were excellent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19877777     DOI: 10.3171/2009.6.PEDS09104

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  19 in total

Review 1.  Endovascular treatment and radiographic follow-up of proximal traumatic intracranial aneurysms in adolescents: case series and review of the literature.

Authors:  Daniel H Fulkerson; Jason M Voorhies; Shannon P McCanna; Troy D Payner; Thomas J Leipzig; John A Scott; Andrew J DeNardo; Kathleen Redelman; Terry G Horner
Journal:  Childs Nerv Syst       Date:  2010-02-23       Impact factor: 1.475

2.  Flow-diverter stenting of post-traumatic bilateral anterior cerebral artery pseudoaneurysm: A case report.

Authors:  Andrea Giorgianni; Carlo Pellegrino; Renzo Minotto; Anna Mercuri; Lara Frattini; Fabio Baruzzi; Luca Valvassori
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

3.  Endovascular treatment of a traumatic carotid artery aneurysm after endoscopic arachnoid cyst fenestration.

Authors:  Felipe Padovani Trivelato; Marco Túlio Salles Rezende; Alexandre Cordeiro Ulhôa; Alexandre Varella Giannetti
Journal:  Childs Nerv Syst       Date:  2011-06-21       Impact factor: 1.475

Review 4.  Off-label use of drugs and devices in the neuroendovascular suite.

Authors:  M M Abdihalim; A E Hassan; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-21       Impact factor: 3.825

5.  Intracranial pseudoaneurysm after intracranial pressure monitor placement.

Authors:  Kushal J Shah; Aaron M Jones; Paul M Arnold; Koji Ebersole
Journal:  BMJ Case Rep       Date:  2014-12-12

6.  Endovascular Management of Vascular Injury during Transsphenoidal Surgery.

Authors:  C Cinar; H Bozkaya; M Parildar; I Oran
Journal:  Interv Neuroradiol       Date:  2013-03-04       Impact factor: 1.610

7.  Lenticulostriate artery aneurysm presenting as primary intraventricular haemorrhage.

Authors:  Trilochan Srivastava; Raghavendra Bakki Sannegowda; Bhawna Sharma; Shankar Tejwani
Journal:  BMJ Case Rep       Date:  2013-06-26

8.  Idiopathic lenticulostriate artery pseudoaneurysm protruding into the lateral ventricle: a case report.

Authors:  Tackeun Kim; Jae Seung Bang; Gyojun Hwang; O-Ki Kwon; Chang Wan Oh; Kyung Han Nam
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2013-09-30

9.  Pipeline embolization for an iatrogenic intracranial internal carotid artery pseudoaneurysm after transsphenoidal pituitary tumor surgery: Case report and review of the literature.

Authors:  Yasuhiko Nariai; Yosuke Kawamura; Tomoji Takigawa; Akio Hyodo; Kensuke Suzuki
Journal:  Interv Neuroradiol       Date:  2019-09-10       Impact factor: 1.610

10.  Onyx embolization of a ruptured anterior inferior cerebellar artery in a neonate.

Authors:  Travis S CreveCoeur; Afshin Salehi; Brandon A Miller; Matthew J Austin; Dewitte T Cross; Matthew D Smyth
Journal:  Childs Nerv Syst       Date:  2018-09-10       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.